Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.266 | 0.2319 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.266 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.266 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0021 | 0.0901 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.0901 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0034 | 0.4524 | 0.4775 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.266 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0048 | 0.8487 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.266 | 0.2319 |
Echinococcus multilocularis | dna polymerase eta | 0.0048 | 0.8487 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0034 | 0.4524 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0034 | 0.4524 | 0.4775 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0.0901 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0.0901 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0048 | 0.8487 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0048 | 0.8487 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0048 | 0.8487 | 0.8487 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.5303 | 0.5303 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.0901 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0048 | 0.8487 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0021 | 0.0901 | 0.5 |
Brugia malayi | hypothetical protein | 0.0027 | 0.266 | 0.266 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.0901 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.266 | 0.1934 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.5303 | 0.4837 |
Schistosoma mansoni | DNA polymerase eta | 0.0048 | 0.8487 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.266 | 0.2319 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.266 | 0.2319 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0021 | 0.0901 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0021 | 0.0901 | 0.0901 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.8487 | 0.8338 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.5303 | 0.5802 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase of survival time of host | ChEMBL. | 376849 | |
Activity (functional) | Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase of survival time of host at 640 mg/kg | ChEMBL. | 376849 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.